Nat Rev Neurol 12(8):455464 Global regional (2018) and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 19902017: a systematic analysis for the Global Burden of Disease Study 2017
Oxidative damage markers decreased by up to 72% (NIH)
Research shows that GLP-1 users should aim for roughly 1.2 grams of protein per kilogram of body weight per day to preserve lean muscle mass while the scale goes down
Yes, clinics frequently pair CJC1295 or CJC1295 with DAC with peptides like Ipamorelin, BPC157, or TB500 to create synergistic stacks for performance, recovery, or joint support
June 23, 2026Download PDF Story at-a-glance GLP-1 drugs such as Ozempic and Wegovy have been linked to serious vision concerns, including diabetic retinopathy and optic nerve damage that can result in lasting vision loss Research suggests the highest risk of sudden vision loss may occur within the first year of starting these drugs, with symptoms sometimes appearing overnight without pain or warning Case reports document that even healthy adults using GLP-1 drugs for weight loss with no history of diabetes or eye disease have experienced lasting vision loss Sudden changes in vision such as blurriness, blind spots, or loss of color perception may be early warning signs of optic nerve damage
